| Literature DB >> 26862571 |
Elyse A Dunn1, Gregory M Cook2, Adam Heikal2.
Abstract
The energy-generating membrane protein NADH dehydrogenase (NDH-2), a proposed antibacterial drug target (see "Inhibitors of type II NADH:menaquinone oxidoreductase represent a class of antitubercular drugs" Weinstein et al. 2005 [1]), was screened for modulators of activity in either detergent-solublised or lipid reconstituted (proteolipsome) form. Here we present an annotated list of compounds identified in a small-scale screen against NDH-2. The dataset contains information regarding the libraries screened, the identities of hit compounds and the physicochemical properties governing solubility and permeability. The implications of these data for future antibiotic discovery are discussed in our associated report, "Comparison of lipid and detergent enzyme environments for identifying inhibitors of membrane-bound energy-transducing proteins" [2].Entities:
Year: 2015 PMID: 26862571 PMCID: PMC4706612 DOI: 10.1016/j.dib.2015.12.019
Source DB: PubMed Journal: Data Brief ISSN: 2352-3409
Inhibitors/activators of detergent-solubilized (DS) or lipid-reconstituted (LR) NDH-2 activity, detected by screening compound libraries.
| LOPAC | I-OMe-Tyrphostin AG 538 | 3 | 5 | 437.19 | 2 | 40±6.7 | 41.9±27.0 |
| LOPAC | Myricetin | 6 | 8 | 318.24 | 0 | 42±14.2 | 29.9±22.4 |
| LOPAC | Morin | 5 | 7 | 302.24 | 2 | 32±31.2 | 18.7±12.1 |
| LOPAC | Nordihydroguaiaretic acid (NDGA) | 4 | 4 | 302.37 | 4 | 33±24.4 | 18.7±23.1 |
| LOPAC | Reactive blue 2 | 5 | 11 | 840.11 | 1* | 44±7.3 | 36.53±44.5 |
| LOPAC | Tyrphostin AG 538 | 4 | 5 | 297.27 | 1 | 37±7.4 | 38.1±28.2 |
| LOPAC | Tyrphostin AG 698 | 3 | 3 | 308.34 | 1 | 63±2.1 | 67.6±2.3 |
| LOPAC | Tyrphostin AG 528 | 2 | 3 | 308.34 | 3 | 54±21.2 | 55.3±15.9 |
| LOPAC | Indirubin-3′-oxime | 3 | 2 | 277.28 | 2 | 50±12.1 | 47.6±25.6 |
| LOPAC | Hispidin | 3 | 5 | 246.22 | 0 | 48±3.2 | 53.7±19.4 |
| LOPAC | Tyrphostin AG 537 | 6 | 6 | 448.44 | 1 | 22±18.4 | 57.0±16..9 |
| LOPAC | 2,6-Difluoro-4-[2-(phenylsulfonylamino) ethylthio]phenoxyacetamide (PEPA) | 3 | 4 | 402.44 | 2 | 136±3.1 | 133.7±15.2 |
| LOPAC | Caffeic acid phenethyl ester | 2 | 4 | 284.31 | 4 | 43±9.0 | N/A |
| LOPAC | Piceatannol | 4 | 4 | 244.25 | 3 | 35±5.5 | N/A |
| LOPAC | Tyrphostin AG 808 | 3 | 3 | 304.31 | 2 | 7±16.5 | N/A |
| LOPAC | 4-Chloromercuribenzoic acid | 1 | 2 | 257.16 | 2* | 48±0.3 | N/A |
| LOPAC | WIN 62,577 | 1 | 1 | 438.58 | 5 | 142±1.8 | N/A |
| LOPAC | MJ33 | 1 | 7 | 514.49 | 8* | 149±22.7 | N/A |
| LOPAC | Pentylenetetrazole | 0 | 0 | 138.17 | 0 | 132±2.9 | N/A |
| LOPAC | Kenpaullone | 2 | 1 | 327.18 | 5 | 65±2.9 | N/A |
| LOPAC | Pregnenolone sulphate sodium | 0 | 5 | 418.53 | 1* | 68±1.1 | N/A |
| LOPAC | Phloretin | 4 | 2 | 274.28 | 1 | 65±3.8 | N/A |
| LOPAC | Farnesylthiosalicylic acid | 1 | 2 | 358.55 | 7 | 61±1.4 | N/A |
| LOPAC | Tyrphostin AG 555 | 3 | 3 | 322.37 | 3 | 53±1.2 | N/A |
| LOPAC | Suramin hexasodium | 6 | 23 | 1429.19 | 3* | 61±10.0 | N/A |
| LOPAC | Rottlerin | 5 | 8 | 516.55 | 1* | 57±6.1 | N/A |
| NIH | 6H-Benzofuro[3,2-c] [1] benzopyran-6-one, 3,9-dihydroxy- | ND | ND | 268.23 | ND | 65±22.2 | N/A |
| NIH | 6H-Pyrido[4,3-b]carbazole, 5,11-dimethyl- | ND | ND | 246 | ND | 65±28.1 | N/A |
| NIH | Michellamine B diacetic acid salt | ND | ND | 877 | ND | 54±31.2 | N/A |
| NIH | [9,9′-bi-4H-Naphtho[2,3-b]pyran]-4,4′-dione, 2,2′,3,3′-tetrahydro-5,5′,6,6′,8,8′-hexahydroxy-2,2′,3,3′-tetramethyl- | ND | ND | 547 | ND | 33±11.5 | N/A |
| NIH | Mangostin | ND | ND | 410 | ND | 19±15.3 | N/A |
| Quinonolone Quinone | Compound 18b | ND | ND | 375.46 | ND | 41±22.7 | 46±19.8 |
| Quinonolone Quinone | Compound 19 | ND | ND | 377.48 | ND | 36±16.1 | 38±5.1 |
Compound libraries were screened for inhibitors of NDH-2 NADH oxidation. Libraries screened included the Library of Pharmacologically Active Compounds (LOPAC), The NIH (National Institutes of Health) Natural Products Set II, and the Quinolinequinone Library.
ND=value not determined.
Data variation is expressed as standard deviation, N/A=not applicable.
| Subject area | |
| More specific subject area | |
| Type of data | |
| How data was acquired | |
| Data format | |
| Experimental factors | |
| Experimental features | |
| Data source location | |
| Data accessibility |